Creo Medical Group
Update in progressCREO.L (LSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Creo Medical Group PLC develops, manufactures, and sells medical devices for clinics and hospitals in the United Kingdom. It markets CROMA, an energy platform combining bipolar radiofrequency cutting with microwave coagulation, delivered via endoscope. Its range includes Speedboat Inject, MicroBlate Fine and Flex, SpydrBlade Flex, and endoscopy accessories such as needles, clips, snares, and forceps, plus devices for GI, pulmology, and urology. Founded 2003, based in Chepstow.
Company score
- Sentiment
- 0.32
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.00
- Governance
- 0.09
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.17
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!